KOLAYA

KOLAYA Biomedical Co., Ltd. was established in 2020 as a high-tech enterprise integrating research and development, production, and sales. Headquartered in Taizhou Medical High-Tech Industrial Development Zone — China Medical City, located in the central area of the Yangtze River Delta. The company adheres to the core concept of "Integrity builds quality, innovation leads the future," and is committed to providing society with high-quality medical devices and excellent health services.KOLAYA Biomedical carries forward the corporate spirit of "Rigor, pragmatism, focus." Over the past three years, through relentless efforts and progress, it has built a 6,000-square-meter standard cleanroom workshop, introduced outstanding domestic production and testing equipment, and its total assets have reached 14.0859 million yuan. At the same time, the company has made great efforts to enhance its core competitiveness to meet the needs of multi-variety and large-scale industrial production.KOLAYA Biomedical focuses on the medical device industry, with 55 employees, including 10 core R&D personnel: one postdoctoral researcher, two doctors, two masters, and five undergraduates. The R&D team has extensive scientific research experience and strong R&D management capabilities. The company invests a high proportion of resources in R&D and registration, aiming to build an international-level medical testing product R&D platform. It has signed university-enterprise cooperation agreements with multiple domestic universities, continuously improving R&D capabilities and management levels. Several products developed by the company have applied for invention patents and obtained multiple utility model patent certificates, and they have passed the registration of various domestically produced medical devices in China, further enhancing the technical performance and application effects of the products and expanding market share.